Introduction
The Mamaearth IPO, floated by Honasa Consumer Limited, became one of the most discussed public issues in India’s recent capital-market discourse. The controversy was not merely about whether investors liked or disliked the valuation. The deeper question was legal: can a prospectus be technically compliant with law, and yet still leave investors with an incomplete commercial impression?
Honasa Consumer Limited filed its Draft Red Herring Prospectus with SEBI in December 2022, and SEBI’s public filing page records the DRHP under “Draft Offer Documents filed with SEBI” on 30 December 2022. The Red Herring Prospectus was later filed in October 2023, with SEBI’s public record showing the RHP filing on 25 October 2023.
The issue attracted public debate because Honasa Consumer, the parent company of Mamaearth, sought a valuation that many market observers considered aggressive when compared with its then profitability, advertising expenditure, and business fundamentals. Yet, this is where law and market sentiment part ways. A high valuation is not automatically illegal. A confident business narrative is not automatically misleading. An IPO that makes investors uncomfortable is not, for that reason alone, a defective IPO.
The real issue is more nuanced: Indian securities law is built on disclosure, not regulatory endorsement of valuation. SEBI does not ordinarily sit as a commercial valuer of a company. Its function is to ensure that material information is disclosed so that investors can assess the risk for themselves.
That distinction is the heart of the Mamaearth IPO debate.
The Factual Background: What Happened in the Mamaearth IPO?
Honasa Consumer Limited’s public issue was priced in the band of ₹308 to ₹324 per equity share of face value ₹10 each. The abridged prospectus recorded the minimum bid lot as 46 equity shares, with the offer opening on 31 October 2023 and closing on 2 November 2023.
The IPO was proposed to be listed on both BSE Limited and the National Stock Exchange of India Limited. The abridged prospectus also disclosed that the fresh issue component involved gross proceeds of ₹3,650 million, and that the company would not receive proceeds from the Offer for Sale portion.
One of the key disclosures was the proposed use of fresh issue proceeds. Honasa disclosed that ₹1,820 million was proposed for advertisement expenses towards enhancing brand awareness and visibility. This was significant because the company’s business model, like many digital-first consumer brands, depended heavily on brand-building, customer acquisition and marketing spend.
The abridged prospectus also contained a number of risk factors. These included risks relating to changing consumer preferences, brand reputation, unsuccessful product launches, prior issuance of shares at prices below the offer price, ESOP-related profit-and-loss impact, and reliance on third-party manufacturers.
Legally, therefore, the question is not whether the valuation looked ambitious. The question is whether the offer documents disclosed enough material information for investors to make an informed decision.
That is where the distinction between legal disclosure and commercial transparency becomes crucial.
The Legal Framework: Prospectus Disclosure Under Indian Law
Indian law treats a prospectus as a serious legal document. It is not a marketing brochure dressed up in legal clothing. A prospectus is the primary document through which the investing public is invited to subscribe to securities, and therefore, it carries statutory consequences.
Section 26 of the Companies Act, 2013 requires a prospectus to contain prescribed information, including details relating to the company, financial information, risk factors, objects of the issue, management, litigation, and other material particulars.
Sections 34 and 35 of the Companies Act, 2013 deal with consequences of misstatements in a prospectus. Section 34 concerns criminal liability for untrue or misleading statements, while Section 35 concerns civil liability where investors suffer loss after subscribing on the basis of a misleading prospectus.
Alongside the Companies Act, public issues are governed by the SEBI ICDR Regulations, 2018. These regulations prescribe the disclosure architecture for capital issues, including offer documents, eligibility requirements, risk factors, financial statements, objects of the issue and related disclosures. SEBI’s official record identifies the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 as the governing regulatory framework for such issues.
The combined effect is clear: the law does not require the company to guarantee returns. Nor does it require SEBI to certify that the valuation is fair. What the law requires is full, fair and material disclosure.
Disclosure-Based Regulation: What SEBI Does and Does Not Do
A common misconception among retail investors is that if an IPO is cleared by SEBI, the company’s valuation has been “approved” by the regulator. That is legally incorrect.
The Honasa abridged prospectus itself made this clear. It stated that investors must rely on their own examination of the company and the offer, including the risks involved, and further recorded that the equity shares had neither been recommended nor approved by SEBI, nor did SEBI guarantee the accuracy or adequacy of the contents of the RHP.
This disclaimer is not ornamental. It reflects the backbone of India’s capital-market regime.
SEBI’s approach is largely disclosure-based. The regulator checks whether the issuer has made the required disclosures and complied with applicable regulations. It does not usually decide whether a business is worth the price being asked by promoters, selling shareholders or merchant bankers. That decision is left to the market.
This model has logic. If SEBI were to decide whether every IPO valuation was “fair”, the regulator would effectively become a super-investment committee. That would slow capital formation, interfere with market pricing, and create a dangerous illusion that all regulator-cleared investments are commercially safe.
The market must price risk. The regulator must ensure disclosure. Confusing the two is where many investor grievances begin.
Was the Mamaearth IPO Legally Defective?
On the available public material, the stronger legal position is that the controversy was not one of clear statutory violation, but of valuation discomfort.
Honasa disclosed the price band, issue timelines, risk factors, offer structure, objects of the issue, use of proceeds, prior share acquisition costs and relevant investor warnings. The company also certified in the abridged prospectus that applicable provisions of the Companies Act, SEBI regulations and other relevant securities laws had been complied with, and that the statements, disclosures and undertakings in the RHP were true and correct.
The prospectus also disclosed weighted average cost of acquisition figures for shares transacted by promoters, promoter group and selling shareholders in the last one year, eighteen months and three years. This type of disclosure is important because it allows investors to compare the offer price with historical acquisition costs and decide whether the valuation appears justified.
Therefore, unless a specific statement was false, misleading in context, or a material fact was omitted in a manner likely to mislead investors, mere disagreement with valuation would not automatically trigger prospectus liability.
That is the hard truth. The law does not punish optimism. It punishes deception.
The Real Problem: Lawful Disclosure Can Still Be Commercially Misleading
The phrase “lawful but misleading” must be understood carefully. It does not mean that Honasa necessarily violated the law. Rather, it points to a broader structural issue in IPO disclosures.
A company may disclose all legally mandated information and still present its story in a manner that emphasises growth, brand strength, market opportunity and future potential, while the less attractive realities remain buried inside dense risk-factor language.
This is not unique to Mamaearth. It is a recurring feature of modern IPOs, especially in consumer-tech, digital-first, platform-based and startup-backed businesses.
The disclosure may be legally complete, but the investor experience may still be imperfect because:
- Risk factors are often technically drafted and not easily digestible for ordinary investors.
- Valuation narratives may depend heavily on future growth assumptions.
- Offer documents may disclose data without explaining its commercial significance.
- Retail investors may treat brand familiarity as a substitute for financial analysis.
- High marketing visibility may create a perception of financial strength that is not always proportionate to profitability.
This is the disclosure gap: not absence of information, but difficulty in converting disclosed information into sound investment judgment.
In other words, the problem may not be that the investor was denied information. The problem may be that the investor was drowned in information.
Prospectus Misstatement vs Aggressive Valuation
For a prospectus to attract legal consequences, the issue must generally go beyond “I think the company is overpriced.”
There must be a legally relevant defect: an untrue statement, a misleading statement, a statement misleading by context, or omission of a material fact likely to mislead. Sections 34 and 35 of the Companies Act are aimed at such misstatements and consequent investor harm.
Aggressive valuation, by itself, is not necessarily misstatement. A valuation is ultimately an opinion, estimate or market-driven conclusion. It may be ambitious. It may be commercially debatable. It may even prove wrong after listing. But unless it is supported by false assumptions, suppressed material information or fraudulent inducement, it will usually remain within the realm of market risk.
This is particularly relevant in IPOs of new-age companies where traditional valuation metrics may not fully capture brand, scale, consumer recall, digital distribution and future expansion potential. At the same time, such valuations must be approached with caution because future promise is not the same thing as current earnings.
A mature investor must ask:
Is the company profitable, scalable, defensible and fairly priced?
A regulator asks a narrower question:
Has the company disclosed the material facts required by law?
Both questions matter. But they are not the same.
Judicial Approach: Substance Over Form, But Not Merit Regulation
Indian courts have repeatedly recognised the importance of investor protection in securities regulation. In SEBI v. Sahara India Real Estate Corporation, the Supreme Court dealt with public fundraising and SEBI’s regulatory jurisdiction over securities offerings. The judgment is often cited for the principle that capital raising cannot be structured in a manner that defeats investor-protection obligations.
Similarly, in PGF Ltd. v. Union of India, the Supreme Court upheld SEBI’s role in addressing collective investment schemes and protecting investors where financial arrangements are structured in a manner that may affect public interest.
However, these cases should not be misunderstood. They do not convert SEBI into a commercial judge of valuation. The judicial approach supports substance over form where investor protection is at stake, but it does not require the regulator to decide whether every IPO is a good investment.
That is the fine legal balance:
SEBI must prevent deception. It need not prevent every bad investment decision.
What the Mamaearth IPO Teaches Investors
The Mamaearth IPO debate offers an important lesson for retail and institutional investors alike. Brand popularity is not the same as investment safety. A company may be famous, widely consumed and heavily marketed, but the investor must still examine revenue quality, profitability, margins, acquisition costs, cash flows, promoter exits, offer-for-sale size, use of proceeds and risk factors.
The abridged prospectus specifically warned bidders that investment in equity and equity-related securities involves risk and that bidders should not invest unless they can afford to lose their investment. That warning is not a formality. It is the legal system’s blunt way of saying: capital markets are not fixed deposits wearing a blazer.
Investors must especially examine:
- Whether the IPO proceeds are going into company growth or primarily providing exit to existing shareholders.
- Whether the company’s valuation is supported by earnings, growth, margins or merely brand narrative.
- Whether risk factors are generic or materially connected to the business model.
- Whether past share acquisition costs materially differ from the IPO offer price.
- Whether future profitability depends on continued advertisement expenditure.
- Whether the business has strong entry barriers or only high customer-acquisition spending.
The Mamaearth debate shows that disclosure is only useful if investors actually read and interpret it.
What Companies and Merchant Bankers Should Learn
The lesson for issuers is equally clear. Legal compliance should not be treated as a minimum defensive exercise. A public issue document should not merely survive regulatory scrutiny; it should enable meaningful investor understanding.
Companies and merchant bankers should present risk factors in a manner that is legally precise but commercially intelligible. Valuation rationale should be more than a technical justification. It should help investors understand why the offer price is reasonable despite profitability concerns, growth-stage economics or heavy marketing spends.
In an era of retail participation, disclosure documents must bridge the gap between legal adequacy and investor comprehension. If a company’s defence is only that “everything was somewhere disclosed in the document,” that may be legally sufficient, but it does not inspire confidence.
For capital markets to mature, disclosure must move from box-ticking to meaningful explanation.
The Fastrack Legal Solutions View
The Mamaearth IPO controversy does not prove that India’s disclosure-based regulatory model is defective. On the contrary, the model remains commercially sound. A regulator should not decide whether a company is too expensive. The market must retain that freedom.
However, the controversy does show that the next frontier of investor protection is not merely more disclosure. It is better disclosure.
India does not need a return to merit-based regulation where authorities decide which companies deserve public money. That would be paternalistic and commercially inefficient. But India does need sharper disclosure standards, simpler risk presentation, clearer valuation explanations and stronger accountability for selective narrative-building.
The future of securities regulation lies in balancing three interests:
First, companies must be allowed to raise capital without regulatory overreach.
Second, investors must receive full and comprehensible information.
Third, regulators must intervene where disclosure becomes technically compliant but substantively evasive.
That is the real legal lesson from the Mamaearth IPO.
Conclusion
The Mamaearth IPO debate is not merely about one company, one valuation, or one market controversy. It is a useful case study in the limits of disclosure-based regulation.
A prospectus may comply with the law and yet leave investors debating whether the commercial picture was sufficiently clear. That does not automatically make the prospectus unlawful. But it does raise an important policy question: should disclosure be judged only by the presence of information, or also by the clarity with which that information is presented?
The answer must lie somewhere in the middle.
SEBI should not become a valuation court. Investors cannot be relieved of their duty to analyse. Companies cannot be prohibited from presenting their business with confidence. But where public money is involved, disclosure must not become a legal maze through which only analysts and lawyers can walk safely.
The Mamaearth IPO ultimately reinforces a simple principle:
the law protects informed choice, not profitable choice.
And in capital markets, that distinction makes all the difference.
Disclaimer
This article is intended solely for general informational and educational purposes and does not constitute legal advice, investment advice, financial advice, solicitation, advertisement, or an invitation to avail legal services. The discussion is based on publicly available information, statutory provisions, regulatory materials, and general principles of Indian securities law as understood at the time of writing.
Nothing contained herein should be construed as a legal opinion on the merits of any specific IPO, company, security, transaction, investor claim, or regulatory proceeding. Readers and investors are advised to conduct their own independent due diligence and consult qualified legal, financial, tax, or investment professionals before taking any decision.
Fastrack Legal Solutions LLP and the author disclaim any liability arising from reliance placed on the contents of this article. The references to Mamaearth, Honasa Consumer Limited, SEBI, or any related public issue are used only for academic, legal, and analytical discussion.
FAQs
1. Was the Mamaearth IPO illegal?
There is no clear basis, on available public material, to say that the Mamaearth IPO was illegal merely because its valuation was debated. The key legal test is whether the offer document contained false, misleading or materially incomplete disclosures.
2. Does SEBI approval mean an IPO is a good investment?
No. SEBI does not recommend or approve an IPO as a good investment. The Honasa abridged prospectus itself stated that the equity shares were neither recommended nor approved by SEBI and that SEBI did not guarantee the accuracy or adequacy of the RHP.
3. What is a prospectus misstatement?
A prospectus misstatement may arise where the document contains an untrue or misleading statement, or omits material information in a manner likely to mislead investors. Sections 34 and 35 of the Companies Act, 2013 deal with criminal and civil liability for such misstatements.
4. Can an overvalued IPO be challenged legally?
A high or aggressive valuation alone is generally not enough. A legal challenge would require evidence of misrepresentation, suppression of material facts, fraud, or misleading disclosure.
5. What is the main lesson from the Mamaearth IPO?
The main lesson is that investors must distinguish between legal compliance and investment merit. A company may disclose the required information, but investors must still independently assess valuation, business risk and financial fundamentals.
Article By Taruna Kanwar Intern at Fastrack Legal Solutions